Morgan Stanley lowered the firm’s price target on Roche (RHHBY) to CHF 286 from CHF 312 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY:
- Genentech announces CENTERSTONE trial data published in NEJM
- Trump Trade: Auto makers exempt from some U.S. tariffs
- Roche seeking U.S. tariff relief in direct talks with White House, Reuters says
- Roche Holding AG: Mixed Q1’25 Results and Strategic U.S. Investments Justify Hold Rating
- Roche sees FY25 core EPS growing in high single digit range